ZELTIQ Aesthetics Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 16 Posts
Four Consecutive Trading Sessions With Record Highs
Article By: Marvin R Clark Tuesday, February 14, 2017 11:31 PM EDT
Federal Reserve Chair Janet Yellen said the labor market is basically where the Fed wants it to be, and inflation is just a little lower than their target.
In this article: AET, AGN, CI, CS, FCX, GM, HUM, T, VZ, TOSBF, CYNO, HOLX, ZLTQ, TMUS, ANTM, QSR, PLKI, LITE
Read
E Allergan To Acquire Zeltiq Aesthetics For $2.48B, $56.50 Per Share
Article By: Jacob Maslow Tuesday, February 14, 2017 6:39 AM EDT
Allergan announced on Monday that the company will acquire Zeltiq Aesthetics in a $2.48 billion deal. The company's failed merger with Pfizer Inc. last year has led to Allergen Chief Executive Brent Saunders acquiring several companies.
In this article: AGN, ZLTQ Also: PFE
Read
Wall Street Hit Record Highs Again
Article By: Marvin R Clark Monday, February 13, 2017 11:56 PM EDT
Wall Street hit record highs again. Stock markets around the world were higher this morning. The S&P 500’s market value topped $20 trillion.
In this article: AGN, DIS, TOSBF, ORCL, ZLTQ, JJC, GOOGL
Read
Allergan Plc. Announces Intention To Acquire Zeltiq Aesthetics
Article By: Lorimer Wilson Monday, February 13, 2017 12:12 PM EDT
Pharma giant Allergan plc. is adding another line of cosmetic treatments to its portfolio, announcing today that it will acquire body contouring specialist ZELTIQ Aesthetics for nearly $2.5 billion in cash.
In this article: AGN, ZLTQ
Read
5 Small Caps For Momentum Investors - 19 September, 2016
Article By: Jim Van Meerten Monday, September 19, 2016 1:10 PM EDT
Today's watch list includes: Zeltiq Aesthetics, Supernus Pharma, Mimedx, Marcus and IIVI Inc.
In this article: ZLTQ, SUPN, MCS, IIVI, MDXG
Read
E Best And Worst In Small Cap - July 28, 2016
Article By: E.B. Capital Markets Thursday, July 28, 2016 9:40 AM EDT
The average small cap score this week is 53.84. In our universe, the average small cap is trading -27.37% below its 52 week high, 6.53% above its 200 dma, and has 7.18 days to cover held short.
In this article: BGC, FBC, HZO, MEI, SRI, XOXO, NG, SIMO, TSYS, AMED, CFNL, BCOR, MSTR, QLGC, SCHN, SNBC, TCBK, ZLTQ, EBIX, DRD
Read
E Best And Worst Small Caps - July 21, 2016
Article By: E.B. Capital Markets Thursday, July 21, 2016 1:34 PM EDT
In our small cap universe, the average stock is trading -27.23% below its 52 week high, 7.77% above its 200 dma, and has 7.15 days to cover held short.
In this article: AHS, ETH, HW, NCI, NCS, SRI, XOXO, NG, SA, BEAT, SIGM, SIMO, TSYS, ZEUS, BOOM, CCRN, CFNL, CNMD, EZPW, FLWS, HURN, PROV, SNBC, ZLTQ, EBIX
Read
E Medical Tech M&A Analysis: Neuro, Orthopedic, Aesthetics And Specialty
Article By: Joe Kunkle Wednesday, June 8, 2016 7:04 AM EDT
In the final part of my series looking at Med-Tech M&A landscape I focus on a diverse group of names, and come to find XENT is the most compelling.
In this article: HAE, CYNO, CNMD, IART, WMGI, ZLTQ, XENT, ENTL, PEN, NVRO Also: LDRH, ZBH
Read
My Secrets To 297%+ Gains In Biotech Investing
Article By: Bret Jensen Tuesday, May 12, 2015 5:50 PM EDT
Over the years, I have a developed a strategy I have dubbed “Shotgun Investing” for the small cap biotech arena. This involves holding many small stakes in myriad promising smaller concerns...
In this article: D-STEM (DEFUNCT), JUNO, KITE, ZIOP, NVAX, LCI, ZLTQ
Read
2 Triple Digit Winners For Under $2
Article By: Bret Jensen Wednesday, January 21, 2015 8:12 AM EDT
Small companies in the biotech, medical device, and biopharma spaces are inherently volatile and tend to have many bumps in the road as they try to establish their businesses in a very competitive market.
In this article: NAVB, ETRM, ZLTQ, LCI, AGEN, HALO
Read
Zeltiq Aesthetics - Chart Of The Day
Article By: Jim Van Meerten Tuesday, January 20, 2015 5:32 PM EDT
Zeltiq Aesthetics Inc. is a medical technology company engaged in designing, development and commercialization of non-invasive procedures for the reduction of unwanted fat tissue.
In this article: ZLTQ
Read
Fat Busting By Injection
Article By: IPO Candy Tuesday, November 18, 2014 1:42 PM EDT
Neothetics is on the road now to fund the continued development of their injection-based approach to fat loss. It’s a smallish deal of $4.3M shares, with a $13-15 price range.
In this article: ZLTQ, KYTH
Read
Invest Like Kim Kardashian
Article By: Zacks Investment Research Monday, November 17, 2014 5:36 PM EDT
In the news today due to a merger with Actavis that values Allergan at $66 billion, Allergan is a Zacks Rank #2 (Buy).
In this article: AGN, SKX, ZLTQ, ACT
Read
E Zeltiq (ZLTQ) Is Growing Into Their Valuation
Article By: IPO Candy Tuesday, October 28, 2014 1:28 PM EDT
We've paid some attention and even owned ZLTQ at one time as a way to play into the desires of people to improve their appearance. It's a proven market. Zeltiq reports earnings tonight and so far the company has executed well.
In this article: ZLTQ
Read
Athenahealth Q3 Earnings Fall But Beat Estimates
Article By: Zacks Investment Research Saturday, October 18, 2014 6:33 AM EDT
ATHN reported October 16
In this article: ATHN, OMCL, ZLTQ, GWPH
Read
Medtech Shifts From High Gear Into Overdrive: Canaccord’s William Plovanic
Article By: The Life Sciences Report Wednesday, August 20, 2014 4:06 AM EDT
Rapid growth in the medical device industry and changes in the regulatory environment have propelled valuations in the medtech sector to the high end of the range.
In this article: JNJ, MDT, VRX, DXCM, ETRM, EXAC, NUVA, PODD, ELOS, ZLTQ
Read
1 to 16 of 16 Posts